AZ-4217: a high potency BACE inhibitor displaying acute central efficacy in different in vivo models and reduced amyloid deposition in Tg2576 mice. (Q42710724)
Jump to navigation
Jump to search
scientific article published on June 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | AZ-4217: a high potency BACE inhibitor displaying acute central efficacy in different in vivo models and reduced amyloid deposition in Tg2576 mice. |
scientific article published on June 2013 |
Statements
AZ-4217: a high potency BACE inhibitor displaying acute central efficacy in different in vivo models and reduced amyloid deposition in Tg2576 mice (English)
Susanna Eketjäll
Juliette Janson
Fredrik Jeppsson
Alexander Svanhagen
Karin Kolmodin
Susanne Gustavsson
Ann-Cathrin Radesäter
Kristina Eliason
Sveinn Briem
Paulina Appelkvist
Camilla Niva
Anna-Lena Berg
Sofia Karlström
Britt-Marie Swahn
Johanna Fälting
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference